Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods.
Messori, Andrea
Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods. [electronic resource] - Journal of endocrinological investigation Aug 2014 - 769-773 p. digital
Publication Type: Journal Article; Meta-Analysis
1720-8386
10.1007/s40618-014-0124-3 doi
Alendronate--pharmacokinetics
Antibodies, Monoclonal, Humanized--pharmacokinetics
Bone Density Conservation Agents--pharmacokinetics
Denosumab
Diphosphonates--pharmacokinetics
Etidronic Acid--analogs & derivatives
Evidence-Based Medicine
Female
Humans
Ibandronic Acid
Incidence
Osteoporosis, Postmenopausal--drug therapy
Osteoporotic Fractures--epidemiology
Randomized Controlled Trials as Topic
Risedronic Acid
Spinal Fractures--epidemiology
Therapeutic Equivalency
Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods. [electronic resource] - Journal of endocrinological investigation Aug 2014 - 769-773 p. digital
Publication Type: Journal Article; Meta-Analysis
1720-8386
10.1007/s40618-014-0124-3 doi
Alendronate--pharmacokinetics
Antibodies, Monoclonal, Humanized--pharmacokinetics
Bone Density Conservation Agents--pharmacokinetics
Denosumab
Diphosphonates--pharmacokinetics
Etidronic Acid--analogs & derivatives
Evidence-Based Medicine
Female
Humans
Ibandronic Acid
Incidence
Osteoporosis, Postmenopausal--drug therapy
Osteoporotic Fractures--epidemiology
Randomized Controlled Trials as Topic
Risedronic Acid
Spinal Fractures--epidemiology
Therapeutic Equivalency